Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information

First Received Date ^†

August 12, 2005

Last Updated Date

November 15, 2007

Start Date ^†

August 2005

Current Primary Outcome Measures ^†

To implement an evidence based screening, assessment, treatment, and referral guideline for hematology/oncology patients with NP receiving care [ Time Frame: outcome measures will consist of the NPVAS, and a PPCPS adapted rom the original project. Adequate satisfaction will be defined as 25% or mor of all patients reporting being very or completely satisfied as measured by PPCPS ]

Original Primary Outcome Measures ^†

Same as current

Change History

Complete list of historical versions of study NCT00130130 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^†

Original Secondary Outcome Measures ^†

Descriptive Information

Brief Title ^†

Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes

Official Title ^†

Testing the Effects of an Algorithm for Neuropathic Pain on Patient and System Outcomes

Brief Summary

The overall purpose of this project is to improve nurse skills regarding neuropathic pain (NP) assessment, treatment and referral practices through implementation of an evidence-based algorithm and to improve selected patient outcomes as a result of algorithm use.

Detailed Description

Neuropathic pain (NP) is defined as pain that arises from injury, disease or dysfunction of the central or peripheral nervous system. For the patient focused phase of the project NP treatment will be guided via the Peripheral Neuropathy Treatment Algorithm. Patients will receive algorithm-specific treatment for 12 weeks.

Study Phase

Phase I, Phase II

Study Type ^†

Observational

Study Design ^†

Case-Only, Prospective

Condition ^†

Pain

Intervention ^†

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^†

Active, not recruiting

Enrollment ^†

Estimated Completion Date

August 2006

Primary Completion Date

Eligibility Criteria ^†

Inclusion Criteria:

Cancer patients experiencing NP from a variety of causes
NP Visual Analogue Scale (VAS) score equal to or > 4 with 12 week estimated duration
Karnofsky Performance Status (KPS) 60% or greater
Age greater than 18

Exclusion Criteria:

Patients undergoing anticancer or invasive pain procedures specifically intended to palliate NP are ineligible

Gender

Both

Ages

18 Years to 90 Years

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

United States

Expanded Access Status

Administrative Information

NCT ID ^†

NCT00130130

Responsible Party

Secondary IDs ^††

ONS

Study Sponsor ^†

Dartmouth-Hitchcock Medical Center

Collaborators ^††

Investigators ^†

Principal Investigator:

Ellen Lavoie-Smith, ARNP

Dartmouth-Hitchcock Medical Center

Information Provided By

Dartmouth-Hitchcock Medical Center

Verification Date

November 2007

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.